# Pentapharm, Ltd.

- Location (FDA's records): Washington, DC
- FDA decisions: 3 (2004–2010): 3 510(k) clearances
- Names in FDA's records: Pentapharm , Ltd. (2); Pentapharm GmbH (1)
- Product codes: GGN (1), GGW (1), JPA (1)
- Predicates its devices cite: 3 (0 its own); citations of its devices by later devices: 2 (0 its own)
- Recalls linked to its devices: 2 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Chromogenix AB: 2 (https://510kreport.com/company/chromogenix)
- Haemoscope Corp.: 1 (https://510kreport.com/company/haemoscope)

## Firms that cite its devices most
- Hemosonics, LLC: 1 (https://510kreport.com/company/hemosonics)
- Tem Innovations GmbH: 1 (https://510kreport.com/company/tem-innovations)

## Its most-cited devices
- K083842: Rotem Delta Thromboelastometry System (2010), cited by 2

## Recent decisions
- K083842: Rotem Delta Thromboelastometry System (Mar 23, 2010)
- K042760: Pefakit Apc-R Factor V Leiden Controls (Dec 22, 2004)
- K042762: Pefakit Apc-R Factor V Leiden (Dec 22, 2004)

Source page: https://510kreport.com/company/pentapharm